{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:01:42Z","timestamp":1792033302064,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ijid.2025.108171","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:00:39Z","timestamp":1761843639000},"page":"108171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Immunogenicity and safety of Ebola vaccines in children: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"162","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7193-1900","authenticated-orcid":false,"given":"Marianna","family":"Zarro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsiaryna","family":"Bashlakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Dellisanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Brunone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Villari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"De Vito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Rosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2025.108171_bib0001","unstructured":"Ebola disease n.d. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/ebola-disease [accessed 29 May 2025]."},{"key":"10.1016\/j.ijid.2025.108171_bib0002","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0140-6736(18)31710-0","article-title":"Prevention of Ebola virus disease through vaccination: where we are in 2018","volume":"392","author":"L\u00e9vy","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2025.108171_bib0003","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41390-023-02873-y","article-title":"Ebola virus disease in children: epidemiology, pathogenesis, management, and prevention","volume":"95","author":"Dobbs","year":"2024","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ijid.2025.108171_bib0004","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/20469047.2020.1805260","article-title":"Review of Ebola virus disease in children - how far have we come?","volume":"41","author":"Dixit","year":"2021","journal-title":"Paediatr Int CHILD Health"},{"key":"10.1016\/j.ijid.2025.108171_bib0005","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1056\/NEJMc1415318","article-title":"Ebola virus disease among children in West Africa","volume":"372","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2025.108171_bib0006","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40475-019-00195-w","article-title":"Maternal and infant death and the rVSV-ZEBOV vaccine through three recent ebola virus Epidemics-West Africa, DRC \u00c9quateur and DRC Kivu: 4 years of excluding pregnant and lactating women and their infants from immunization","volume":"6","author":"Schwartz","year":"2019","journal-title":"Curr Trop Med Rep"},{"key":"10.1016\/j.ijid.2025.108171_bib0007","doi-asserted-by":"crossref","first-page":"360","DOI":"10.15585\/mmwr.mm7316a1","article-title":"Use of Ebola vaccines \u2014 worldwide, 2021\u20132023","volume":"73","author":"Kallay","year":"2024","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijid.2025.108171_bib0008","unstructured":"Ervebo | European Medicines Agency (EMA) n.d. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/ervebo [accessed 30 May 2025]."},{"key":"10.1016\/j.ijid.2025.108171_bib0009","unstructured":"ERVEBO | FDA n.d. https:\/\/www.fda.gov\/vaccines-blood-biologics\/ervebo [accessed 3 June 2025]."},{"key":"10.1016\/j.ijid.2025.108171_bib0010","unstructured":"Mvabea | European Medicines Agency (EMA) n.d. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/mvabea [accessed 30 May 2025]."},{"key":"10.1016\/j.ijid.2025.108171_bib0011","unstructured":"Zabdeno | European Medicines Agency (EMA) n.d. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/zabdeno [accessed 30 May 2025]."},{"key":"10.1016\/j.ijid.2025.108171_bib0012","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ijid.2025.108171_bib0013","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ijid.2025.108171_bib0014","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/mt.2016.83","article-title":"Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants","volume":"24","author":"Afolabi","year":"2016","journal-title":"Mol Ther"},{"key":"10.1016\/j.ijid.2025.108171_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(23)00410-2","article-title":"Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone","volume":"11","author":"Choi","year":"2023","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijid.2025.108171_bib0016","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1473-3099(21)00128-6","article-title":"Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial","volume":"22","author":"Afolabi","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2025.108171_bib0017","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/cid\/ciad693","article-title":"Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSV\u0394G-ZEBOV-GP Ebola Vaccine (ERVEBO\u00ae): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults","volume":"78","author":"Lee","year":"2024","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.ijid.2025.108171_bib0018","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1056\/NEJMoa2200072","article-title":"Randomized trial of vaccines for zaire Ebola virus disease","volume":"387","author":"Kieh","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2025.108171_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106237","article-title":"Replication, safety and immunogenicity of the vectored Ebola vaccine rVSV-\u0394G-ZEBOV-GP in a sub-Saharan African pediatric population: A randomised controlled, open-label trial in children aged 1-12 years living in Lambar\u00e9n\u00e9, Gabon","volume":"89","author":"Alabi","year":"2024","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2025.108171_bib0020","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/infdis\/jiac283","article-title":"Monitoring of adverse events in recipients of the 2-dose Ebola vaccine regimen of Ad26.ZEBOV followed by MVA-BN-Filo in the UMURINZI Ebola vaccination campaign","volume":"227","author":"Nyombayire","year":"2023","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2025.108171_bib0021","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1473-3099(20)30019-0","article-title":"Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial","volume":"20","author":"Tapia","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2025.108171_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003865","article-title":"Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: a randomised, placebo-controlled, multicentre Phase II clinical trial","volume":"19","author":"Anywaine","year":"2022","journal-title":"PLoS Med"},{"issue":"27","key":"10.1016\/j.ijid.2025.108171_bib0023","first-page":"355","volume":"99","year":"2024","journal-title":"Weekly Epidemiological Record = Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire"},{"key":"10.1016\/j.ijid.2025.108171_bib0024","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5588\/pha.16.0120","article-title":"Influence of the 2014-2015 Ebola outbreak on the vaccination of children in a rural district of Guinea","volume":"7","author":"Camara","year":"2017","journal-title":"Public Health Action"},{"key":"10.1016\/j.ijid.2025.108171_bib0025","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S1473-3099(17)30110-X","article-title":"Asymptomatic Ebola virus infections\u2014myth or reality?","volume":"17","author":"Kuhn","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2025.108171_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(20)30198-1","article-title":"Estimation of the correlates of protection of the rVSV\u0394G-ZEBOV-GP Zaire ebolavirus vaccine: a post-hoc analysis of data from phase 2\/3 clinical trials","volume":"2","author":"Grais","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ijid.2025.108171_bib0027","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1093\/infdis\/jiab243","article-title":"Baseline asymptomatic malaria infection and immunogenicity of recombinant vesicular stomatitis virus\u2013Zaire Ebola virus envelope glycoprotein","volume":"224","author":"Mahon","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2025.108171_bib0028","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.1016\/j.vaccine.2022.09.037","article-title":"Immunogenicity of rVSV\u0394G-ZEBOV-GP Ebola vaccine (ERVEBO\u00ae) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: a post hoc analysis of three Phase 2\/3 trials","volume":"40","author":"Simon","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2025.108171_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002402","article-title":"Safety and immunogenicity of rVSV\u0394G-ZEBOV-GP Ebola vaccine in adults and children in Lambar\u00e9n\u00e9, Gabon: a phase I randomised trial","volume":"14","author":"Agnandji","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2025.108171_bib0030","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.4269\/ajtmh.17-0820","article-title":"Food insecurity as a risk factor for outcomes related to ebola virus disease in Kono district, Sierra Leone: a cross-sectional study","volume":"98","author":"Kelly","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijid.2025.108171_bib0031","unstructured":"Epicentre. An open-label, single arm study to provide additional information on safety and effectiveness of rVSV\u0394G-ZEBOV-GP. ClinicalTrials.gov. Identifier: NCT03161366. https:\/\/clinicaltrials.gov\/study\/NCT03161366; 2018. [accessed 11 November, 2025]"},{"key":"10.1016\/j.ijid.2025.108171_bib0032","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28986","article-title":"Inequitable access to Ebola vaccines and the resurgence of Ebola in Africa: a state of arts review","volume":"95","author":"Abdul-Rahman","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.ijid.2025.108171_bib0033","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1093\/infdis\/jix336","article-title":"Rapid establishment of a cold chain capacity of \u201360\u00b0C or Colder for the STRIVE Ebola vaccine trial during the Ebola outbreak in Sierra Leone","volume":"217","author":"Jusu","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2025.108171_bib0034","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fpubh.2019.00056","article-title":"Vaccine production in Africa: a feasible business model for capacity building and sustainable new vaccine introduction","volume":"7","author":"Makenga","year":"2019","journal-title":"Front Public Health"},{"key":"10.1016\/j.ijid.2025.108171_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2021.100119","article-title":"The importance of vaccine stockpiling to respond to epidemics and remediate global supply shortages affecting immunization: strategic challenges and risks identified by manufacturers","volume":"9","author":"Jarrett","year":"2021","journal-title":"Vaccine X"},{"key":"10.1016\/j.ijid.2025.108171_bib0036","unstructured":"Ebola virus disease: Vaccines n.d. https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/ebola-vaccines [accessed 30 May 2025]."},{"key":"10.1016\/j.ijid.2025.108171_bib0037","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1126\/science.aaa3438","article-title":"Reduced vaccination and the risk of measles and other childhood infections post-Ebola","volume":"347","author":"Takahashi","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ijid.2025.108171_bib0038","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S1473-3099(17)30541-8","article-title":"Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report","volume":"17","author":"Gsell","year":"2017","journal-title":"Lancet Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225003935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225003935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T12:33:14Z","timestamp":1766406794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971225003935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":38,"alternative-id":["S1201971225003935"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108171","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of Ebola vaccines in children: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108171"}}